Philip Bonomi

11.9k citations
241 papers · 8.0k · 1 hit paper · h-index 42

Impact in

  • Oncology top 0.2%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 134
    • Lung Cancer Diagnosis and Treatment 57
    • Lung Cancer Research Studies 65
    • Colorectal Cancer Treatments and Studies 24
    • Cancer Treatment and Pharmacology 22
    • Cancer Immunotherapy and Biomarkers 20

Philip Bonomi

235 papers receiving 7.7k citations

Philip Bonomi's Hit Papers

Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer 2004 · 893 citations
8930+7+14Years since publication250500750

Peers

Philip Bonomi
Comparison fields: 5 of 127
  • Oncology 4.9k
  • Pulmonary and Respiratory Medicine 4.4k
  • Cancer Research 978
  • Obstetrics and Gynecology 293
  • Hepatology 274
Replace Francesco Perrone with:
Francesco Perrone Italy
Peter Harper United Kingdom
Guru Sonpavde United States
Ashley E. Winkler United States
Rogério Lilenbaum United States
Jyoti D. Patel United States
Maciej Krzakowski Poland
Anthony Elias United States
Cristina Nanni Italy
Vassilis Georgoulias Greece
Philip Bonomi relative to Francesco Perrone Italy Francesco Perrone's profile →
Citations per field
00.5×1.5×2.4×
Francesco Perrone · 1×
Citations per year

Countries citing papers authored by Philip Bonomi

Since Specialization
Citations

This map shows the geographic impact of Philip Bonomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Bonomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Bonomi more than expected).

Fields of papers citing papers by Philip Bonomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Bonomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Bonomi. The network helps show where Philip Bonomi may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip Bonomi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Bonomi Line = papers co-authored together Philip Bonomi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 241 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer
Hit paper breakdown →
2004893
2 2000479
3 2007336
4 1985326
5 2013281
6 1989278
7 2004213
8 2008184
9 2018173
10 2018155
11 2008142
12 2009139
13 2017137
14 1989136
15 2008125
16 2016111
17 2003109
18
A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
1985109
19 2007109
20 200495

About Philip Bonomi

Philip Bonomi is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Epidemiology, having authored 241 papers that have together received 8.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (134 papers), Lung Cancer Research Studies (65 papers), Lung Cancer Diagnosis and Treatment (57 papers), Colorectal Cancer Treatments and Studies (24 papers), Cancer Treatment and Pharmacology (22 papers), Cancer Immunotherapy and Biomarkers (20 papers), Nutrition and Health in Aging (18 papers) and Cancer Genomics and Diagnostics (13 papers). The work is most often cited by research in Oncology (4.9k citations), Pulmonary and Respiratory Medicine (4.4k citations), Cancer Research (978 citations), Obstetrics and Gynecology (293 citations) and Hepatology (274 citations). Philip Bonomi has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Eric K. Rowinsky, L. Penfield Faber, Daniel D. Karp, Mary J. Fidler, Lisa A. Hammond, James R. Rigas, P. Santabárbara, Abraham Chachoua, Román Pérez-Soler and Mark S. Huberman. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Lung Cancer, International Journal of Radiation Oncology*Biology*Physics and The Annals of Thoracic Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact